Dr. Tadaki M. Tomita, MD

Dr. Tomita practices at Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois.

Dr. Tomita's NPI, 1376706317, was assigned on July 9, 2008. Dr. Tomita graduated from Northwestern University Feinberg Medical School in 2008. Dr. Tomita holds Illinois license 036.131798.

Dr. Tomita's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital, at 1000 N Westmoreland Rd, Lake Forest, IL 60045 in Lake County. The practice phone is (847) 234-5600.

Dr. Tomita's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois. Dr. Tomita is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Tomita to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tomita practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Tomita's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Tomita is licensed in Illinois.

CMS data shows 2,297 Medicare services from Dr. Tomita across 24 procedure codes in 2024, for 1,510 Medicare patients. Medicare paid $162,442 for them.

CMS counts 1,510 Medicare patients who saw Dr. Tomita in 2024. The largest group is 75 to 84, with 604 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tomita's median patient age at 71, with 51% women.

In 2024, Dr. Tomita wrote 35 Medicare Part D claims for 23 patients. 94% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $50 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Tomita for performance year 2024, reported through an alternative payment model (APM). Dr. Tomita accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tomita as offering telehealth. CMS counts 23 procedures of leg revascularization (restoring blood flow) by Dr. Tomita, more than 83% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Tomita, published from 2016 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Blood Vessel Prosthesis Implantation, Peripheral Arterial Disease and Blood Vessel Prosthesis. Dr. Tomita has published most often in J Vasc Surg. Dr. Tomita's most frequent co-authors are Mark K. Eskandari, MD, Andrew Warfield Hoel, MD and Heron E. Rodriguez, MD.

CMS Open Payments shows 36 general payments to Dr. Tomita from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. W. L. Gore & Associates, Inc. paid the most, $2,339.

Dr. Tomita graduated from Northwestern University Feinberg Medical School in 2008.